Science
Ny akanjo tsy hita maso, ny biolojia sintetika, ny simia mahatsikaiky, ary ny fivoaran'ny eritreritra siantifika — ity pejy ity dia mirakitra ireo fironana sy vaovao izay hitarika ny hoavin'ny siansa.
256465
famantarana
https://www.nature.com/articles/s41598-024-59884-w?code=dcc221e3-6d58-4623-8de1-f3e402b3b9d2&error=cookies_not_supported
famantarana
Nature
Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1059-1064. https://doi.org/10.1093/gerona/61.10.1059 (2006).Article
PubMed
Google Scholar
Janssen, I.,...
PubMed
Google Scholar
Janssen, I.,...
256466
famantarana
https://www.foxnews.com/health/cancer-trends-revealed-including-common-types-disease-and-biggest-risk-factors
famantarana
Foxnews
Dr. Marc Siegel reacts to what is behind rising cancer cases among young adults and advises to eat a healthy diet, cut back on alcohol consumption, and get the HPV vaccine Almost 40% of Americans will receive a cancer diagnosis at some point in their lifetime — but certain types are more common...
256467
famantarana
https://twistedsifter.com/2024/04/could-alzheimers-spread-through-blood-transfusions-new-research-suggests-a-link/
famantarana
Twistedsifter
Alzheimer's has one of the biggest research funds of any disease out there, and for good reason. It affects many, and is devastating not only for the people suffering from it, but those who love them. Now, scientists are finding evidence that it could be spread through a simple blood transfusion. Researchers have suspected for a long time that more than genetic factors are at play.
256469
famantarana
https://www.medpagetoday.com/podcasts/healthwatch/109958
famantarana
Medpagetoday
TTHealthWatch dia podcast isan-kerinandro avy amin'ny Texas Tech. Ao anatin'izany, Elizabeth Tracey, talen'ny haino aman-jery elektronika ho an'ny Johns Hopkins Medicine any Baltimore, ary Rick Lange, MD, filohan'ny Texas Tech University Health Sciences Center any El Paso, dia mijery ireo tantara ara-pitsaboana ambony indrindra amin'ny herinandro.
Amin'ity herinandro ity...
Amin'ity herinandro ity...
256491
famantarana
https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-fasenra-copd-approval/
famantarana
Pharmaceutical-teknolojia
AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic phenotype, in children aged 6-11 years in more than 80 countries, including the US, EU, and Japan.
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
FOTOANA HO AVY
FIRENENA FIRENENA
256490
famantarana
https://www.beingpatient.com/what-are-biologics-for-alzheimers/
famantarana
Mahari-po
Raha hitanao fa manampy ny lahatsoratra sy ny dinidinikay, miangavy anao mba ho tonga mpikambana mpanohana ao amin'ny vondrom-piarahamoninay. Sorena noho ny tsy fahampian'ny loharanom-baovao tsy miankina amin'ny famoahana momba ny fahasalaman'ny ati-doha sy ny aretin'i Alzheimer, nanapa-kevitra ny hamorona Being Patient izahay. Ekipa mpanao gazety manokan-tena izahay mitantara ny fikarohana farany momba ny Alzheimer' mitondra anao miditra amin'ireo manam-pahaizana ary manandratra ny fomba fijerin'ny marary momba ny fiainana miaraka amin'ny dementia.
FOTOANA HO AVY
FIRENENA FIRENENA
256489
famantarana
https://time.com/6972086/ozempic-anti-inflammatory-drug/
famantarana
Time
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn's disease as a teenager, the multiple...
FOTOANA HO AVY
FIRENENA FIRENENA
256488
famantarana
https://www.nature.com/articles/d41586-024-01215-0?code=49a116c5-eeb3-4ba2-8fd0-34d9c9e00371&error=cookies_not_supported
famantarana
Nature
US drug regulators dropped a bombshell in November 2023 when they announced an investigation into one of the most celebrated cancer treatments to emerge in decades. The US Food and Drug Administration (FDA) said it was looking at whether a strategy that involves engineering a person's immune cells to kill cancer was leading to new malignancies in people who had been treated with it.
FOTOANA HO AVY
FIRENENA FIRENENA
256487
famantarana
https://www.finsmes.com/2024/04/surf-bio-receives-1-6m-non-dilutive-grant-from-bill-melinda-gates-foundation.html
famantarana
Finsmes
Surf Bio Receives $1.6M Non-Dilutive Grant From Bill & Melinda Gates Foundation
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Mikasa ny...
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Mikasa ny...
FOTOANA HO AVY
FIRENENA FIRENENA
256486
famantarana
https://www.finsmes.com/2024/04/enlaza-therapeutics-raises-100m-in-series-a-financing.html
famantarana
Finsmes
Enlaza Therapeutics, a La Jolla, CA-based covalent biologic platform company, raised $100M in Series A funding.
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
FOTOANA HO AVY
FIRENENA FIRENENA
256485
famantarana
https://www.statnews.com/2024/04/30/economics-holding-back-promise-antibody-therapies-infectious-diseases/
famantarana
Statnews
Next-generation broadly neutralizing antibodies (bnAbs) have the potential to transform the fight against global health threats like HIV, malaria, and Ebola. The commercialization of these innovative antibody therapies could save millions of lives annually. But turning promise into reality...
256468
famantarana
https://www.cnbc.com/2024/05/05/within-a-few-years-generative-ai-will-design-new-drugs-on-its-own.html
famantarana
Cnbc
The advances related to AI are taking place within a field of biology that has been increasingly digitized at what Powell describes as "unprecedented scales and resolutions." It's a medical revolution that includes spatial genomics scanning millions of cells within tissue, in 3-and AI model-building that specifically benefits from a catalog of chemicals already in a digital form which allows generative AI transformer models to now go to work on them.
256484
famantarana
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-promising-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-302131482.html
famantarana
Prnewswire
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia relative to lurasidone - never previously shown with an oral antidepressant. Suicidality signal met the...
256483
famantarana
https://www.fda.gov/news-events/press-announcements/fda-roundup-april-30-2024
famantarana
levitra
For Immediate Release:
Aprily 30, 2024
Androany, ny US Food and Drug Administration dia manome famintinana vetivety momba ny vaovao avy amin'ny masoivoho:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
Aprily 30, 2024
Androany, ny US Food and Drug Administration dia manome famintinana vetivety momba ny vaovao avy amin'ny masoivoho:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
256482
famantarana
https://www.cnbc.com/2024/05/01/healthy-returns-humira-sales-are-falling-but-abbvie-has-successors.html
famantarana
Cnbc
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of 's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.and abroad. . That was clear after AbbVie on Friday reported first-quarter revenue and adjusted profit that topped Wall Street's expectations, partly driven by strength in the drugmaker's immunology business.
256481
famantarana
https://www.csrwire.com/press_releases/800871-jazz-pharmaceuticals-focuses-taking-actions-positively-impact-planet-earth
famantarana
Csrwire
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology.
256471
famantarana
https://www.forbes.com/sites/joshuacohen/2024/05/03/medicare-says-it-expects-to-spend-35-billion-in-2025-on-alzheimers-drug-leqembi-but-this-is-unlikely/
famantarana
Forbes
ABINGTON, PA - NOV 7: Nurse Christine Besso, center, helps Robert Williford, 66, left, during his ... [+] first session of receive the newly FDA approved Alzheimer's treatment Leqembi while Williford's wife Cynthia Byron-Williford, 59, right, watches at Abington Neurological Associates in...
256473
famantarana
https://www.jmir.org/2024/1/e48572/
famantarana
Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study
Jmir
Introduction In recent years, the issue of drug toxicity has emerged as a serious concern in the fields of clinical medicine, pharmacology, and sociology. As a result, drug regulatory agencies worldwide are making continuous efforts to monitor marketed drugs and assess their potential risks in...
256472
famantarana
https://www.finsmes.com/2024/05/latus-raises-54m-in-series-a-financing.html
famantarana
Finsmes
Latus Bio, a Philadelphia, PA-based biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), raised $54M in Series A funding.
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
256479
famantarana
https://www.healio.com/news/dermatology/20240501/eli-lillys-firstquarter-financial-results-highlight-resubmission-of-bla-for-lebrikizumab
famantarana
Healio
Enga anie 01, 2024
Namaky 1 aho
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Ampio lohahevitra amin'ny fampandrenesana mailaka
Nampiana tamin'ny mailaka fanairana
Tsy afaka nikarakara ny fangatahanao izahay. Andramo indray rahatrizay. Raha ianao...
Namaky 1 aho
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Ampio lohahevitra amin'ny fampandrenesana mailaka
Nampiana tamin'ny mailaka fanairana
Tsy afaka nikarakara ny fangatahanao izahay. Andramo indray rahatrizay. Raha ianao...
256470
famantarana
https://www.startribune.com/thousands-believe-covid-vaccines-harmed-them-is-anyone-listening/600363571/
famantarana
Startribune
Within minutes of getting the Johnson & Johnson COVID-19 vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her fingertips. Within days, she was unbearably sensitive to light and struggled to remember simple facts. She was 37, with a doctorate in neuroscience, and until then could ride her bicycle 20 miles, teach a dance class and give a lecture on artificial intelligence, all in the same day.
256480
famantarana
https://www.pharmaceutical-technology.com/news/enlaza-series-a-funding/
famantarana
Pharmaceutical-teknolojia
Enlaza Therapeutics has raised $100m in a Series A financing round headed by the Life Sciences group of JP Morgan Asset Management's private capital division.
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...